Hong H - Search Results

1

In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers.

Cai C, Fang J, Guo P, Wang Q, Hong H, Moslehi J, Cheng F. Cai C, et al. Among authors: hong h. J Chem Inf Model. 2018 May 29;58(5):943-956. doi: 10.1021/acs.jcim.7b00641. Epub 2018 May 10. J Chem Inf Model. 2018. PMID: 29712429 Free PMC article.

2

Toward predictive models for drug-induced liver injury in humans: are we there yet?

Chen M, Bisgin H, Tong L, Hong H, Fang H, Borlak J, Tong W. Chen M, et al. Among authors: hong h. Biomark Med. 2014;8(2):201-13. doi: 10.2217/bmm.13.146. Biomark Med. 2014. PMID: 24521015 Free article. Review.

3

Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.

Zhang C, Hong H, Mendrick DL, Tang Y, Cheng F. Zhang C, et al. Among authors: hong h. Biomark Med. 2015;9(11):1241-52. doi: 10.2217/bmm.15.81. Epub 2015 Oct 28. Biomark Med. 2015. PMID: 26506997 Review.

4

Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.

Cheng F, Hong H, Yang S, Wei Y. Cheng F, et al. Among authors: hong h. Brief Bioinform. 2017 Jul 1;18(4):682-697. doi: 10.1093/bib/bbw051. Brief Bioinform. 2017. PMID: 27296652 Review.

5

Development of a Nicotinic Acetylcholine Receptor nAChR α7 Binding Activity Prediction Model.

Sakkiah S, Leggett C, Pan B, Guo W, Valerio LG Jr, Hong H. Sakkiah S, et al. Among authors: hong h. J Chem Inf Model. 2020 Apr 27;60(4):2396-2404. doi: 10.1021/acs.jcim.0c00139. Epub 2020 Mar 24. J Chem Inf Model. 2020. PMID: 32159345

6

Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors.

Sakamuru S, Zhao J, Xia M, Hong H, Simeonov A, Vaisman I, Huang R. Sakamuru S, et al. Among authors: hong h. J Chem Inf Model. 2021 Jun 28;61(6):2675-2685. doi: 10.1021/acs.jcim.1c00439. Epub 2021 May 28. J Chem Inf Model. 2021. PMID: 34047186 Free PMC article.

7

Mold(2), molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics.

Hong H, Xie Q, Ge W, Qian F, Fang H, Shi L, Su Z, Perkins R, Tong W. Hong H, et al. J Chem Inf Model. 2008 Jul;48(7):1337-44. doi: 10.1021/ci800038f. Epub 2008 Jun 20. J Chem Inf Model. 2008. PMID: 18564836

8

Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.

Chen M, Hong H, Fang H, Kelly R, Zhou G, Borlak J, Tong W. Chen M, et al. Among authors: hong h. Toxicol Sci. 2013 Nov;136(1):242-9. doi: 10.1093/toxsci/kft189. Epub 2013 Aug 31. Toxicol Sci. 2013. PMID: 23997115

9

Estrogenic activity data extraction and in silico prediction show the endocrine disruption potential of bisphenol A replacement compounds.

Ng HW, Shu M, Luo H, Ye H, Ge W, Perkins R, Tong W, Hong H. Ng HW, et al. Among authors: hong h. Chem Res Toxicol. 2015 Sep 21;28(9):1784-95. doi: 10.1021/acs.chemrestox.5b00243. Epub 2015 Sep 2. Chem Res Toxicol. 2015. PMID: 26308263

10

Drug Repositioning Through Network Pharmacology.

Ye H, Wei J, Tang K, Feuers R, Hong H. Ye H, et al. Among authors: hong h. Curr Top Med Chem. 2016;16(30):3646-3656. doi: 10.2174/1568026616666160530181328. Curr Top Med Chem. 2016. PMID: 27334200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,498 results

Search Page

Filters